REDHILL BIOPHARMA LTD. Sales And Marketing Expense
REDHILL BIOPHARMA LTD. (RDHL) reported Sales And Marketing Expense of $2.04 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. sales and marketing expense for the quarter ending 2022-06-30 was $9.27M, a 39.13% decline year-over-year.
- REDHILL BIOPHARMA LTD. sales and marketing expense for the quarter ending 2021-06-30 was $15.23M, a 52.90% increase year-over-year.
- REDHILL BIOPHARMA LTD. sales and marketing expense for the quarter ending 2020-06-30 was $9.96M, a 140.27% increase year-over-year.
- REDHILL BIOPHARMA LTD. sales and marketing expense for the quarter ending 2019-06-30 was $4.15M, a 32.79% increase year-over-year.
| Period end | Sales And Marketing Expense 3 month | Sales And Marketing Expense 6 month | Sales And Marketing Expense 12 month |
|---|---|---|---|
| 2025-06-30 | $2.04M 6-K · filed 2025-09-05 | ||
| 2024-12-31 | $5.95M 20-F · filed 2025-04-10 | ||
| 2024-06-30 | $3.49M 6-K · filed 2025-09-05 | ||
| 2023-12-31 | $14.76M 20-F · filed 2025-04-10 | ||
| 2023-06-30 | $9.63M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $35.44M 20-F · filed 2025-04-10 | ||
| 2022-06-30 | $9.27M 6-K · filed 2022-11-07 | $21.83M 6-K · filed 2023-08-17 | |
| 2021-12-31 | $55.62M 20-F · filed 2024-04-08 | ||
| 2021-06-30 | $15.23M 6-K · filed 2022-11-07 | $29.13M 6-K · filed 2022-11-07 | |
| 2020-12-31 | $49.28M 20-F · filed 2023-04-28 | ||
| 2020-06-30 | $9.96M 6-K · filed 2021-08-26 | $18.97M 6-K · filed 2021-08-26 | |
| 2019-12-31 | $18.33M 20-F · filed 2022-03-17 | ||
| 2019-06-30 | $4.15M 6-K · filed 2020-08-13 | $7.28M 6-K · filed 2020-08-13 | |
| 2018-12-31 | $12.49M 20-F · filed 2021-03-18 | ||
| 2018-06-30 | $3.12M 6-K · filed 2019-07-23 | $6.29M 6-K · filed 2019-07-23 | |
| 2017-12-31 | $12.01M 20-F · filed 2020-03-04 | ||
| 2017-06-30 | $3.38M 6-K · filed 2018-08-30 | $3.98M 6-K · filed 2018-08-30 | |
| 2016-12-31 | $1.55M 20-F · filed 2019-02-26 | ||
| 2015-12-31 | $1.39M 20-F · filed 2018-02-22 |